Robert W. Postma - Jun 6, 2024 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Role
Director
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Jun 6, 2024
Transactions value $
$0
Form type
4
Date filed
6/10/2024, 05:00 PM
Previous filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRT Employee Stock Option (right to buy) Award $0 +12.8K $0.00 12.8K Jun 6, 2024 Common Stock 12.8K $1.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon.